MRVI — MARAVAI LIFESCIENCES HOLDINGS, INC.
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1823239 ·
Last close
$7.28
Market Cap
$1.09B
52W High
$9.42
52W Low
$2.80
ADV30
2,343,901
Next earnings
2026-11-04
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2026 | — | — | — | — | — | — | — |
| Jun 2026 | 51,442,000 | 20,650,000 | -15,122,000 | -12,416,000 | 603,746,000 | 70,091,000 | 248,158,000 |
| Mar 2026 | 65,837,000 | 33,701,000 | 720,000 | -3,733,000 | 713,217,000 | 165,922,000 | 344,134,000 |
| Dec 2025 | 49,866,000 | 12,842,000 | -22,529,000 | -35,681,000 | 770,577,000 | 216,890,000 | 397,866,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-25,261,000
Investing CF
$-9,847,000
Financing CF
$-164,271,000
CapEx
$-10,581,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.43
As of
2026-11-08
Balance + Analyst (yfinance extras)
Retained Earnings
$-6,031,000
Inventory
$41,230,000
Receivables
$31,138,000
ST Investments
—
EBIT TTM
$-112,531,000
Pretax Income TTM
$-136,488,000
Interest Exp TTM
$23,957,000
Analysts
6
Yahoo Snapshot (yfinance, live)
Total Revenue
$212,996,000
EBITDA
$-3,740,000
Free Cash Flow
$-3,623,125
Enterprise Value
$1,419,375,360
Total Cash
$70,091,000
Total Debt
$218,099,008
Shares Out
149,254,467
Trailing EPS
$-0.44
Book Value
$1.37
ROE
-33.0%
ROA
-5.7%
Div Yield
0.00%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 185,743,000 | -128,530,000 | -130,773,000 | 770,577,000 | 397,866,000 | 212,379,000 | -57,573,000 |
| Dec 2024 | 259,185,000 | -72,683,000 | -144,846,000 | 1,008,244,000 | 431,035,000 | 325,292,000 | 7,465,000 |
| Dec 2023 | 288,945,000 | -28,468,000 | -119,029,000 | 1,487,450,000 | 697,566,000 | 416,753,000 | 126,224,000 |
| Dec 2022 | 883,001,000 | 566,416,000 | 220,205,000 | 2,282,315,000 | 1,377,072,000 | 545,218,000 | 535,977,000 |
TTM Snapshot
Revenues TTM
$208,775,000
NetIncome TTM
$-77,386,000
OpCashFlow TTM
—
Assets (Latest)
$603,746,000
Forward EPS
$-0.11
Max Pain — expiry 2027-03-19
max pain strike: $5.00 · spot: $7.38 · call oi: 5,763 · put oi: 90
Expected Move to 2027-03-19:
±$3.75
(50.81%) —
implied range
$3.63 –
$11.13
· ATM straddle on $7.50 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| HROW | HARROW, INC. | $1.11B | $29.52 | — |
| CMPS | COMPASS Pathways plc | $1.13B | $7.98 | — |
| MTRI | InMed Pharmaceuticals Inc. | $1.02B | $17.50 | — |
| OMER | OMEROS CORP | $1.01B | $13.92 | — |
| CYRX | Cryoport, Inc. | $999.81M | $19.74 | — |
News headlines (Yahoo Finance, 1h cache)
Why Maravai LifeSciences Holdings (MRVI) Is Up After Raising Revenue Guidance
2026-11-06 07:13 · Yahoo
Maravai LifeSciences (MRVI) Q3 2026 Earnings Call Transcript
2026-11-05 20:28 · Yahoo
Maravai LifeSciences Holdings, Inc. Q3 2026 Earnings Call Summary
2026-11-05 13:30 · Yahoo
What Maravai LifeSciences (MRVI) Said on Its Q3 Earnings Call
2026-11-05 03:14 · Yahoo
Maravai LifeSciences Reports Third Quarter 2026 Financial Results
2026-11-04 21:01 · Yahoo
Maravai LifeSciences Announces November 2026 Investor Conference Schedule
2026-10-29 20:01 · Yahoo
Is Maravai LifeSciences Holdings (MRVI) Priced Too Highly For Its Sales?
2026-10-27 05:14 · Yahoo
Maravai LifeSciences (MRVI) Stock Gets Fair Value Boost On mRNA And CleanCap Optimism
2026-10-17 10:10 · Yahoo
Maravai LifeSciences To Host Earnings Conference Call on Wednesday, November 4, 2026
2026-10-14 20:01 · Yahoo
What Is Maravai’s (MRVI) Comeback Really Worth to Investors?
2026-10-04 19:26 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.